ajitrajasekharan commited on
Commit
c63015b
1 Parent(s): d273f14

Update app.py

Browse files
Files changed (1) hide show
  1. app.py +1 -1
app.py CHANGED
@@ -163,7 +163,7 @@ sent_arr_masked = [
163
  "He was diagnosed with non:__entity__ small:__entity__ cell:__entity__ lung:__entity__ cancer:__entity__",
164
  "There are no treatment options specifically indicated for ACD:__entity__ and physicians must utilize agents approved for other dermatology conditions",
165
  "As ACD:__entity__ has been implicated in apoptosis-resistant glioblastoma (GBM), there is a high medical need for identifying novel ACD-inducing drugs ",
166
- "Patients treated with anticancer chemotherapy drugs ( ACD:__entity__ ) are vulnerable to infectious diseases due to immunosuppression and to the direct impact of ACD:__entity__ on their intestinal microbiota ",
167
  "In the LASOR:__entity__ trial:__entity__ , increasing daily imatinib dose from 400 to 600mg induced MMR at 12 and 24 months in 25% and 36% of the patients, respectively, who had suboptimal cytogenetic responses "
168
  ]
169
 
 
163
  "He was diagnosed with non:__entity__ small:__entity__ cell:__entity__ lung:__entity__ cancer:__entity__",
164
  "There are no treatment options specifically indicated for ACD:__entity__ and physicians must utilize agents approved for other dermatology conditions",
165
  "As ACD:__entity__ has been implicated in apoptosis-resistant glioblastoma (GBM), there is a high medical need for identifying novel ACD-inducing drugs ",
166
+ "Patients treated with anticancer chemotherapy drugs ( ACD:__entity__ ) are vulnerable to infectious diseases due to immunosuppression and to the direct impact of ACD on their intestinal microbiota ",
167
  "In the LASOR:__entity__ trial:__entity__ , increasing daily imatinib dose from 400 to 600mg induced MMR at 12 and 24 months in 25% and 36% of the patients, respectively, who had suboptimal cytogenetic responses "
168
  ]
169